IIPRD
JANUARY 23, 2023
In matters of trade, Trademark, copyright and Patent act as building blocks of protection measures while conferring exclusive right over goods/services for the holder. Amazon often face patent violations with its increasing customer base and involvement of third-party seller. Patent infringement can occur in both of these roles.
The IP Law Blog
JANUARY 18, 2024
Patent and Trademark Office (“USPTO”) states, ” a trademark protects brand names and logos used on goods and services. A patent protects an invention. For example, if you invent a new kind of vacuum cleaner, you would apply for a patent to protect the invention itself.” then it is no longer a trade secret.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SpicyIP
MARCH 7, 2024
This high-profile case revolves around allegations of patent infringement concerning two patents (“Suit Patents”), both relating to ‘Pertuzumab,’ a monoclonal antibody (Mab) biologic used in inhibiting tumor growth.
LexBlog IP
JANUARY 18, 2024
Patent and Trademark Office (“USPTO”) states, ” a trademark protects brand names and logos used on goods and services. A patent protects an invention. For example, if you invent a new kind of vacuum cleaner, you would apply for a patent to protect the invention itself.”
Kashishipr
OCTOBER 13, 2021
Where it is a public sector entity, like a government initiative or a university, there is often the pressure of publishing and disseminating information at the earliest; whereas the private sector is usually free of such challenges, and major consideration is laid on the nature and value of the researched object or invention.
SpicyIP
MARCH 21, 2024
This has allowed parties with political, ideological, and other non-technical opposition to patent applications to unduly delay the process by raising a series of pre-grant challenges.”From A failure to disclose these foreign reports can also lead to trouble for the patentee later during patent infringement proceedings.
SpicyIP
JANUARY 23, 2024
Readers will recall that this Ibrutinib patent controversy started in 2020 when the Opposition Board rejected patent no. IN262968, covering Ibrutinib , on the basis of Laurus’ post-grant opposition due to a lack of inventive step. In an appeal, the IPAB set aside the impugned rejection and restored the above patent.
Expert insights. Personalized for you.
52 
Let's personalize your content